Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samir Parekh

Showing results (91-100 of 162) with videos related to

Pageof 17
Sort By:
Nature Chemical Biology|December 11, 2019
Discovery of a first-in-class EZH2 selective degraderAnqi Ma, Elias Stratikopoulos, Kwang-Su Park, et al.
Bone Marrow Transplantation|May 3, 2025
Extramedullary disease but not paraskeletal disease portends inferior outcomes after CAR T cell therapy in multiple myelomaDarren Pan, Tarek H Mouhieddine, Tianxiang Sheng, et al.
The Journal of Clinical Investigation|March 29, 2016
Evaluation of direct-to-consumer low-volume lab tests in healthy adultsBrian A Kidd, Gabriel Hoffman, Noah Zimmerman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2012
Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047Alexandra M Levine, Ariela Noy, Jeannette Y Lee, et al.
Clinical Nuclear Medicine|July 11, 2025
Comparison of MRI, [18F]FDG-PET/CT, and [18F]FDG-PET/MRI for Initial Staging of Multiple Myeloma: A Systematic Review and Meta-analysisMickael Tordjman, Murat Yuce, Amine Geahchan, et al.
Bone Marrow Transplantation|March 30, 2026
Baseline absolute lymphocyte count, C-reactive protein, and ferritin predict CAR T cell-related toxicities and outcomes in multiple myelomaDarren Pan, Tarek H Mouhieddine, Tianxiang Sheng, et al.
The Journal of Clinical Investigation|July 2, 2016
Evaluation of direct-to-consumer low-volume lab tests in healthy adultsBrian A Kidd, Gabriel Hoffman, Noah Zimmerman, et al.
Cancer Research|February 14, 2016
Dual Targeting of CDK4 and ARK5 Using a Novel Kinase Inhibitor ON123300 Exerts Potent Anticancer Activity against Multiple MyelomaDeepak Perumal, Pei-Yu Kuo, Violetta V Leshchenko, et al.
Blood|October 15, 2016
An oxidative stress-based mechanism of doxorubicin cytotoxicity suggests new therapeutic strategies in ABC-DLBCLYun Mai, J Jessica Yu, Boris Bartholdy, et al.
Journal of Medicinal Chemistry|February 16, 2026
Discovery of a Potent, Selective, and In Vivo Efficacious Covalent Inhibitor for Lysine Methyltransferase SETD8He Chen, Rudra Prasad Dutta, Zhizhong Li, et al.
Pageof 17

Showing results (91-100 of 162) with videos related to

Sort By:
Pageof 17
Nature Chemical Biology|December 11, 2019
Discovery of a first-in-class EZH2 selective degraderAnqi Ma, Elias Stratikopoulos, Kwang-Su Park, et al.
Bone Marrow Transplantation|May 3, 2025
Extramedullary disease but not paraskeletal disease portends inferior outcomes after CAR T cell therapy in multiple myelomaDarren Pan, Tarek H Mouhieddine, Tianxiang Sheng, et al.
The Journal of Clinical Investigation|March 29, 2016
Evaluation of direct-to-consumer low-volume lab tests in healthy adultsBrian A Kidd, Gabriel Hoffman, Noah Zimmerman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2012
Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047Alexandra M Levine, Ariela Noy, Jeannette Y Lee, et al.
Clinical Nuclear Medicine|July 11, 2025
Comparison of MRI, [18F]FDG-PET/CT, and [18F]FDG-PET/MRI for Initial Staging of Multiple Myeloma: A Systematic Review and Meta-analysisMickael Tordjman, Murat Yuce, Amine Geahchan, et al.
Bone Marrow Transplantation|March 30, 2026
Baseline absolute lymphocyte count, C-reactive protein, and ferritin predict CAR T cell-related toxicities and outcomes in multiple myelomaDarren Pan, Tarek H Mouhieddine, Tianxiang Sheng, et al.
The Journal of Clinical Investigation|July 2, 2016
Evaluation of direct-to-consumer low-volume lab tests in healthy adultsBrian A Kidd, Gabriel Hoffman, Noah Zimmerman, et al.
Cancer Research|February 14, 2016
Dual Targeting of CDK4 and ARK5 Using a Novel Kinase Inhibitor ON123300 Exerts Potent Anticancer Activity against Multiple MyelomaDeepak Perumal, Pei-Yu Kuo, Violetta V Leshchenko, et al.
Blood|October 15, 2016
An oxidative stress-based mechanism of doxorubicin cytotoxicity suggests new therapeutic strategies in ABC-DLBCLYun Mai, J Jessica Yu, Boris Bartholdy, et al.
Journal of Medicinal Chemistry|February 16, 2026
Discovery of a Potent, Selective, and In Vivo Efficacious Covalent Inhibitor for Lysine Methyltransferase SETD8He Chen, Rudra Prasad Dutta, Zhizhong Li, et al.
Pageof 17